Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.

Authors

Karsh L, Shore N, Soloway M, Bhat G, Reddy G, Leu SY, Witjes JA.

Journal

Bladder Cancer

Year

2018

Volume

Jul 30

Issue

4(3)

Pages

293-301

21st Century Oncology Physicians

Back
To top